Roger Kai-Cheong Ngan

5PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 01, 2026
Cross-Platform Gene Signature to Predict Survival Outcomes for Nasopharyngeal Carcinoma.

|Aug 04, 2025
Virus-human chromatin interactions reorganise 3D genome and hijack KDM5B for promoting metastasis in nasopharyngeal carcinoma.

Dittman Lai-Shun Chung, Zhaozheng Hou, Ying Wang

|Apr 05, 2022
Exploratory Study of NPC-0501 Trial: Optimal Cisplatin Dose of Concurrent and Induction/Adjuvant Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma.

Wai-Tong Ng, Cheuk-Wai Choi, Barton But

|Aug 26, 2021
Phase II, Randomized Study of Spartalizumab (PDR001), an Anti-PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer.

Caroline Even, Hung-Ming Wang, Shau-Hsuan Li

|Jun 10, 2021
Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study.

Richard S Finn, Masatoshi Kudo, Ann-Lii Cheng

Pageof 1

Frequent Collaborators

3 joint publications

Anne Wing-Mui Lee

3 joint publications

Victor Ho-Fun Lee

2 joint publications

Wei Dai

1 joint publications

Arndt Vogel